Hi All
Long time RAP holder, first time poster.
I for one, do not understand all the negativity surrounding the current downtrend with RAP. nothing and I repeat nothing has fundamentally changed. Over the last 12 months RAP management have built this company form a post RTO speculative play into a potential world class business with a life changing/saving medical diagnostic tool.
The results speak for themselves and for management to secure three of the worlds best hospitals, is a testament to what we as a company are achieving , creating and will offer a global market.
FDA approval will come, patience is key when you are involved in such a market defining company like RAP. I understand that we have had minor delays in relation to the U.S. trials beginning, but on the flip side, we have secured world class hospitals, which will expose RAP to a march larger patient set and in my opinion our target data set will be achieved in a very quick and efficient manner.
FDA approval isn't a quick and easy process, hence why we are taking our time to make sure all the relevant process and training has taken place before we begin, so we get it right the first time, without any issues that may halt our pursuit of market entry in 2017. I for one am happy to wait it out to make sure we have all bases covered.
We have all read the number of informative presentations the company has released, and we know the market and revenue potential, that is why we are trading at the levels we have over the past 3 months. Once trials have been completed and results are announced, this current pause in share price appreciation will be a distant memory as we proceed to FDA approval.
Don't be swayed by negative comments, or commentary from such institutions the Motley Fool, who in my opinion are a disgrace to the investment world. Keep the bigger picture in mind as RAP will be a very successful company for years to come (if we don't get taken over). Management have delivered on all fronts thus far so keep the faith and we will all be rewarded.
DYOR
Expand
